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Abstract 
BACKGROUND: Neonatal respiratory distress syndrome (RDS) caused by decreased surfactant and structural 
lung immaturity. The imbalance between oxidative status and antioxidant defence system was suggested to be an 
important trigger for lung affection with RDS.  
AIM: The goal of the current research was to elucidate the significance of the oxidant/ antioxidant status in the 
pathogenesis of RDS in preterm infants.  
PATIENTS AND METHODS: This controlled study included 31 preterm neonates with RDS and 36 healthy 
preterm neonates. Quantification level of oxidative stress biomarkers; malondialdehyde (MDA) & hydrogen 
peroxide (H2O2) along with antioxidant enzymes activity; catalase (CAT) & superoxide dismutase (SOD) in plasma 
of healthy premature neonates compared with those with RDS.  
RESULTS: status of oxidative stress markers (MDA & H2O2) showed a significant increase with decreased levels 
of antioxidant enzymes activity (CAT & SOD) in neonates with RDS when compared to healthy prematures.  
CONCLUSION: The results obtained in this study indicate that the increased oxidative stress accompanied by 
reduced antioxidant defences may play a significant role in the pathogenesis of respiratory distress in preterm 
newborns. 
 
 
 
Introduction 
 
Oxidative stress is recognised by the 
imbalance between the augmented reactive 
oxygen/nitrogen species and the defect in the 
protective ability of the antioxidants. Free radicals with 
consequent cellular oxidative damage produced by 
oxidative stress seem to be key players in the 
pathogenesis of several new-born diseases, like 
respiratory distress syndrome, bronchopulmonary 
dysplasia, patent ductus arteriosus, necrotising 
enterocolitis, and retinopathy of prematurity, 
periventricular leukomalacia [1]. 
Negi et al., [2] reasoned the onset of neonatal 
respiratory distress syndrome (RDS), previously 
called hyaline membrane disease (HMD) to the 
decreased surfactant and structural lungs immaturity. 
Lung tissue damage which occurs during respiratory 
distress syndrome is not clearly explained yet, but the 
implication of oxidative damage due to reactive 
oxygen and hydrogen species is highly appreciated in 
the etiopathogenesis of this disorder. Preterm 
neonates are more prone to oxidative deterioration 
because of the intracellular antioxidant defence 
system including the anti-oxidant enzymes up-
regulates dramatically during the last trimester of 
pregnancy, and they have low levels of radical 
scavengers and metal-binding proteins such as 
transferrin and ceruloplasmin [3]. They also have 
reduced antioxidant enzymes activity like catalase and 
glutathione peroxidase. The imbalance between 
oxidants and antioxidants results in oxidative damage 
and this problem occurs due to incomplete or 
abnormal intrauterine development [4]. 
Immediately after birth, the sudden increase 
in oxygen supply leads to overproduction of reactive 
oxygen species (ROS) and down-regulation of 
antioxidants. This condition induces the enhancement 
of cytokines and inflammatory mediators (interleukin 
6- interleukin 8- Tumor Necrosis factor -α) expression 
[5]. 
Hamid et al. Oxidative Stress and Anti-Oxidant Markers in Premature Infants with Respiratory Distress Syndrome 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2019 Sep 15; 7(17):2858-2863.                                                                                                                                                2859 
 
Preterm infants, in particular, are exposed to 
many events leading to increased generation of 
reactive oxygen species (ROS) such as hyperoxia, 
mechanical ventilation, inflammation and infection [6]. 
Surfactant is the primary treatment of RDS in 
neonates as it reduces hyperoxia-induced lung 
damage. Surfactant replacement has been found to 
cause antioxidant and anti-inflammatory responses 
[7]. 
Superoxide dismutase (SOD) is the most 
powerful antioxidant and detoxification enzyme. It 
catalyses the disputation of two molecules of 
superoxide anion radical (O2
.-
) to hydrogen peroxide 
(H2O2) and oxygen molecule (O2) [8]. Several 
investigators stated that SOD is the crucial enzyme for 
a proper respiratory function in animal and cellular 
models and the deficiency of SOD activity almost 
induces severe hyperoxic lung injury [9]. Endotracheal 
administration of surfactant increases the activity of 
SOD in type II alveolar cells, demonstrating enzyme 
uptake by liposome during the surfactant recycle 
process [10]. 
Catalase (CAT) is the common antioxidant 
enzyme that utilises oxygen. It catalyses the 
degradation of hydrogen peroxide (H2O2). Both 
superoxide dismutase (SOD) and catalase (CAT) are 
on the top of the first line of the defence system. This 
line is essential in the entire antioxidant defence 
mechanism [8]. Superoxide dismutase (SOD) and 
catalase (CAT) activities have been demonstrated in 
several natural surfactants. They also have scavenger 
activity against hydrogen peroxide (H2O2) [11]. 
Malondialdehyde (MDA) is the major reactive 
aldehyde that results from peroxidation of lipids in the 
biological membranes. It can be used as an indicator 
of tissue damage caused by reactive oxygen species 
(ROS). MDA reacts with DNA and modifies RNA, 
proteins and other biological molecules, and this leads 
to tissue destruction [12]. 
The goal of the current research was to 
elucidate the significance of the oxidant / antioxidant 
status in the pathogenesis of RDS in preterm infants. 
This could be achieved through estimation of the 
plasma levels of oxidative stress indicators (MDA, 
H2O2) and detection of plasma activity of the 
antioxidant indices (SOD, CAT). 
 
 
Patients and Methods 
 
A case-control study was conducted on a total 
of 67 neonates recruited from Neonatology 
Department of El-Galaa Teaching Hospital for 
Obstetrics and Gynecology, Cairo, Egypt. (Between 
April 2018 and October 2018). This study was 
approved by the Medical Ethical Committee of the 
National Research Centre, Egypt. Written informed 
consent for all participants was collected from their 
parents. The case (RDS) group consisted of 31 
preterm babies ≤ 37 weeks with a diagnosis of RDS. 
The control group included 36 healthy preterm new-
borns. Exclusion criteria of the study were an 
infection, intracranial haemorrhage, surgical problems 
and hemolytic diseases.  
Respiratory distress syndrome (RDS) was 
diagnosed with the presence of typical clinical and 
radiological signs of the disease in preterm infants. 
Clinically, if they have tachypnea, grunting and 
cyanosis with several hours of birth required 
mechanical ventilation and typical radiographic 
findings on the chest X-ray. The characteristics of the 
newborns including gestational age, weight, Apgar 
score, surfactant replacement, were obtained from 
Hospital sheets. 
Two mL of heparinised venous blood samples 
were withdrawn from the neonates during the first 72 
hours after birth. Blood specimens were processed to 
separate plasma samples which were stored at -20°C. 
 
Determination of plasma levels of 
 oxidative stress markers 
I Malondialdehyde (MDA):  
Principle: Thiobarbituric acid (TBA) reacts 
with malondialdehyde (MDA) in the acidic medium at 
a temperature of 95°C for 30 min to form the 
thiobarbituric acid reactive product. The absorbance 
of the resultant pink product can be measured at 534 
nm Total thiobarbituric acid reactive materials are 
expressed as MDA [13]. 
 
II Hydrogen Peroxide (H2O2): 
Principle: In the presence of peroxidase (HRP), 
H2O2 reacts with 3, 5-dichloro -2-
hydroxybenzensulfonic (DHBS) acid and 4-
aminophenazon (AAP) to form a chromophore, which 
is measured at 510 nm [14].  
 
2H2O2 + DHBS + AAP                 Quinoneimine Dye + 4H2O  
 
Determination of plasma antioxidant 
 enzyme activity 
I Catalase (CAT):  
Principle: Catalase reacts with a known 
quantity of H2O2. The reaction is stopped after exactly 
one minute with catalase inhibitor.  
 
 
2H2O2                                  2H2O + O2 
 
 
HRP 
Catalase 
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 In the presence of peroxidase (HRP), 
remaining H2O2 reacts with 3, 5-Dichloro -2- 
hydroxybenzene sulfonic acid (DHBS) and 4-
aminophenazone (AAP) to form a chromophore with a 
colour intensity measured at 510 nm inversely 
proportional to the activity of catalase in the original 
samples. 
2H2O2 + DHBS + AAP                  Quinoneimine Dye + 4H2O  
 
II Superoxide Dismutase (SOD) 
Principle: This assay relies on the ability of 
the enzyme to inhibit the phenazine methosulfate –
mediated reduction of nitroblue tetrazolium dye. The 
resultant colour was measured at 560 nm. 
 
Statistical analysis  
Data were collected, verified, coded and 
analysed using the Statistical Package for Social 
Science (SPSS) version 23 (SSPS Inc., Pennsylvania, 
and the USA). Descriptive analysis was performed for 
demographic and clinical characteristics of the cases. 
MDA, H2O2 levels, and CAT, SOD activities were 
expressed as mean ± SD. The comparison between 
the cases and control groups was made using 
student's t-test. A chi-square test was used for 
comparison of non-parametric data.  
 
 
Results 
 
The characteristics of all studied neonates 
and their mothers are illustrated in Table (1). The case 
(RDS) group composed of 31 preterm neonates with a 
mean gestational age 31.2 ± 3.2 weeks having a 
mean birth weight 1740.3 ± 720.0 gm. The control 
group composed of 36 preterm neonates with mean 
gestational age 34.3 ± 1.1 weeks and a mean birth 
weight 2248.6 ± 147.1 gm. New-borns in RDS group 
are more premature and have lower birth weight in 
comparison to the control group (P < 0.005). There is 
no significant difference in the maternal age between 
neonates with respiratory distress syndrome and 
controls (P > 0.05). The mean birth weight and Apgar 
scores at 1 and 5 minutes and the gestational age are 
highly significantly lower in cases (RDS) than controls 
(p < 0.005). 
Most preterm neonates with RDS delivered by 
C.S (80.6%), have no history of premature rupture of 
membranes (71.0%) and 58.1% of them have a 
history of multiple pregnancies.  
Twenty preterms with RDS (64.5%) received 
surfactant therapy. Twenty preterms with RDS 
(64.5%) were on mechanical ventilation.  
Table 1: Characteristics of the studied neonates and their 
mothers 
 Case (RDS) group 
(n = 31) 
Control group 
(n = 36) 
t-Test P 
 Mean ± SD Mean ± SD   
Maternal age (years) 28.97± 7.9 29.4 ± 3.4 t = 0.329 0.743 
Gestational Age (weeks) 31.2 ± 3.2 34.3 ± 1.1 t = 5.348 0.000 
Birth weight (gm)  1740.3 ± 720.0 2248.6 ± 147.1 t = 4.141 0.000 
Apgar score 1
st
 min  3.9 ± 2.05 7.72 ± 0.97 t = 10.059 0.000 
Apgar score 5 min  6.5 ± 1.9 8.7 ± 097 t = 6.248 0.000 
 No (%) No (%)   
Gender:  
Male 
Female 
 
24 (77.4%) 
7 (22.6%) 
 
14 (38.9%) 
22 (61.1%) 
 

2
 = 10.073 
 
0.002 
Delivery mode: 
Vaginal 
CS 
 
6 (19.4%) 
25 (80.6%) 
 
17 (47.2%) 
19 (52.8%) 
 

2
 = 5.738 
 
0.017 
Multiple pregnancies: 
Yes 
No 
 
13 (41.9%) 
18 (58.1%) 
 
6 (16.7%) 
30 (83.3%) 
 

2
 = 5.235 
 
0.022 
Premature rupture of 
membranes: 
Yes 
No 
 
9 (29.0%) 
22 (71.0%) 
 
 
2 (5.6%) 
34 (94.4%) 
 

2
 = 6.690 
 
0.010 
Surfactant: 
Yes 
No 
 
20 (64.5%) 
11 (35.5%) 
 
- 
 
- 
 
- 

2
 = chi-square; t = t-test. 
 
The data in Table 2 represented the plasma 
levels of oxidative stress markers and the activity of 
plasma antioxidant enzymes in neonates with RDS 
and control counterparts. There is a highly significant 
elevation in the levels of the oxidative stress markers 
(MDA, H2O2) in the RDS group versus the control one 
(p < 0.005). The highly significant drop in the activity 
of the antioxidant enzymes (CAT, SOD) is noted in the 
RDS group relative to the control group (p < 0.005).  
Table 2: The oxidant and antioxidants markers in prematures 
with RDS and control group 
 Case (RDS) group 
Mean ± SD 
(n = 31) 
Control group 
Mean ± SD 
(n = 36) 
t p 
Oxidative stress markers:  
MDA mmol/L 7.074 ± 1.88722 2.367± 1.3459 11.753 0.000 
H2O2 mµ/L 0.78100 ± 0.2498 0.25900 ± 0.109 8.274 0.000 
Antioxidants markers:  
SOD U/ml 186.596 ± 47.936 267.244 ± 33.476 -6.218 0.000 
Catalase U/L 352.939 ± 68.421 571.217± 117.812 -7.962 0.000 
 
The correlation between clinical parameters of 
RDS cases is depicted in Table 3. The gestational age 
shows a highly significant positive correlation with 
birth weight, maternal age, Apgar score at 1 and 5 
minutes (P < 0.005). On the contrary, it shows a highly 
significant negative correlation with surfactant therapy 
(P < 0.005). Surfactant therapy shows a highly 
significant positive correlation with gestational age 
and birth weight (P < 0.005).  
Table 3: Correlation between clinical parameters of RDS cases 
(31 newborns) 
 Gestatio
nal Age 
surfacta
nt 
therapy 
Birth 
weight 
Materna
l age 
1st min 
Apgar 
score 
5min 
Apgar 
score 
Gestational 
Age 
Pearson 
Correlation 
1 -0.783
**
 0.910
**
 0.656
**
 0.640
**
 0.638
**
 
Sig. (2-tailed) .000 0.000 0.000 0.000 0.000 
surfactant 
therapy 
Pearson 
Correlation 
-0.783
**
 1 -0.638
**
 -0.367
*
 -0.450
*
 -0.390
*
 
Sig. (2-tailed) 0.000 0.000 0.042 0.011 0.030 
1st min 
Apgar score  
Pearson 
Correlation 
0.640
**
 -0.450
*
 0.763
**
 0.685
**
 1 0.928
**
 
Sig. (2-tailed) 0.000 0.011 0.000 0.000 0.000 
5min Apgar 
score 
Pearson 
Correlation 
0.638
**
 0.390
*
 0.711
**
 0.588
**
 .928
**
 1 
Sig. (2-tailed) 0.000 0.030 .000 .001 .000 
**
P < 0.005 highly significant; 
*
P < 0.05 significant. 
HRP 
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Meanwhile, it shows a significant negative 
correlation with maternal age and Apgar score at 1 & 
5 minutes. The highly significant positive correlation is 
observed between the Apgar score (at 1 & 5 minutes) 
and birth weight as well as maternal age (P < 0.005).  
 
 
Discussion 
 
Neonatal respiratory distress syndrome is a 
major health problem in neonates. It occurs due to 
immature lungs and requires assisted ventilation with 
high oxygen concentration. The pathophysiology of 
RDS is based on the rapid formation of reactive 
oxygen species (ROS) that inhibit the detoxification 
capacity of the antioxidative mechanisms [2]. 
In preterm labour, oxidative stress and other 
oxidative molecules exceed the antioxidant buffering 
capacity leading to lung tissue damage [16]. In our 
study, birth weight and gestational age were 
significantly lower in RDS cases than controls. The 
more prematurity, was the less lung surfactant 
production and more severe RDS. Extremely preterm 
and very low birth weight infants are considered at 
particular risk of oxidative stress because of both 
endogenous and passively acquired exogenous 
defence systems do not mature enough until late in 
the third trimester [17]. 
In the present study, most of the case group 
(RDS group) were born by caesarean section (CS). 
The effect of the type of delivery on the oxidative 
stress experienced by both mother and infant is still 
not clear. Actually, there is a controversial hypothesis 
about the mode of delivery and the generation of 
oxidative stress. Yaacobi et al., [18], stated that there 
is an increased concentration of malondialdehyde in 
vaginal delivery and emergency CS after prolonged 
labour group as compared to elective CS without 
labour. In contrast, Mutlu et al., [19] demonstrated a 
conflicting result as their study reported that CS 
increases total oxidative stress, and oxidative stress 
indices, and lipid hydroperoxide level. 
Gerten et al., [20] concluded that caesarean 
section is an independent risk factor for RDS 
development, and the risk is decreased with labour 
before section. This supports the importance of being 
certain of neonatal lung maturity before taking the 
decision of cesarean delivery mainly when done 
before labor. In our study, as most of the RDS group 
was born by CS, we were not able to identify whether 
the increased levels of the oxidative stress were due 
to the mode of delivery or not. However, Lauire et al., 
[21] found that distressed neonates born by 
caesarean section had high MDA concentration, a 
marker of lipid peroxidation in amniotic fluid and cord 
blood compared to non-distressed neonates delivered 
by vaginal route. Nevertheless, we need to investigate 
the exposure of the mother and neonates to the 
oxidative stress about the mode of delivery.  
In our study, male neonates were more 
significantly affected by RDS than females. This is in 
concordance with the study done by Kaltofen et al., 
[22] who demonstrated that female fetal alveolar cells 
of the saccular stage of lung development have a 
higher alveolar Na transport activity compared to age-
matched male cells. Besides, male androgens 
decrease surfactant production and delay lung 
maturity. 
Most neonates in our study had no history of 
premature rupture of membranes (PROM) and this 
could be explained by the fact that more than 80% of 
our neonates were delivered by C.S. Some reactive 
oxygen species (ROS) during pregnancy may cause 
direct vasoconstriction or inability to vasodilate 
placental blood vessels leading to preterm deliveries 
[23]. 
Multiple pregnancies in our study were 
significantly lower than singletons. After considering 
gestation, twins are not at elevated risk of having RDS 
except at very early gestation [24]. 
Most preterm with RDS in our study received 
surfactant therapy. A study was done by Sardesai et 
al., [25] demonstrated that surfactant therapy 
decreases air leaks and neonatal mortality 
significantly. It also contributed to faster weaning from 
invasive ventilation. Noninvasive surfactant 
administration techniques (atomization or 
aerosolisation) may play an important role in the 
future. Carty et al., [26] mentioned that reactive 
oxygen species (ROS) might interact with protein and 
lipid structures of the lung in addition to pulmonary 
surfactant, leading to the delay of the normal function 
of the lung. Therefore, surfactant administration is 
very important before the start of assisted ventilation 
[27]. 
Preterm in the present study showed 
significantly lower Apgar score at 1
st
 and 5 minutes 
than controls. These results matched with a study 
done by Negi et al., [2], who stated that a low Apgar 
score is indicative of perinatal hypoxia.  
At the present study, there was a significant 
positive correlation between Apgar score and both 
weight and maternal age. A study done by Jerneck 
and Herbst [28] registered higher Apgar score with 
birth weight above 5 kg. 
MDA is a final product of lipid peroxidation. 
The present study showed an increased concentration 
of MDA and H2O2 (oxidative stress markers) in 
neonates with RDS concerning controls. These 
findings are in concordance with those of Negi et al., 
[2]. Furthermore, Zahran et al., [29] recorded an 
increased level of MDA in neonates with RDS, which 
is consistent with our results. Our results also fit the 
study of Dizdar et al., [30] which showed an increase 
in the total oxidant status in preterm infants. These 
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investigators mentioned that lower total antioxidant 
status / total oxidant status is associated with 
increased severity and mortality in these infants. 
Nevertheless, in addition to the elevated 
levels of MDA and H2O2, shown in the present study, 
there was a significant drop in the activity of the 
antioxidant enzymes (SOD and CAT). This imbalance 
between elevated oxidative stress factors and the 
reduced antioxidant enzymes might be a contributing 
factor to the RDS in new-born. It is worth noting that 
the total antioxidant status might serve as a 
prognostic marker in new-borns with RDS and help to 
distinguish high-risk infants [31], [32]. This hypothesis 
is greatly supported by Zahran et al., [33] study, which 
demonstrated that the suppressive activity of SOD, as 
an antioxidant, may lead to neonatal RDS. 
Several studies proved that SOD is a key 
enzyme for optimum respiration in animals and 
cellular models. The absence of SOD3 activity 
increases massive lung tissue damage, while SOD2 
overexpression in type II alveolar cells may lead to 
prolonged survival in a hyperoxic environment [9]. 
Aerosol delivered SOD improved alveolar 
development in RDS patients and reduced the 
occurrence of bronchopulmonary dysplasia caused by 
prematurity and mechanical ventilation [33]. A 
previous study of Dani et al., [34] demonstrated that 
commercial natural lung surfactants contain a 
significant concentration of SOD and CAT. These 
surfactants enhance scavenger activity against H2O2 
and are effective in reducing oxidative lung damage.  
It has been shown that while preterm with 
RDS developing Bronchopulmonary dysplasia (BPD), 
they typically exhibit increased CAT enzyme activity in 
the epithelial lung fluid during the first week of life. 
Those preterms with simple RDS showed decreasing 
values of oxyradical inflammation markers during the 
disease course [35]. 
Antioxidants have a vital role in defence 
against free radical-induced lung tissue damage in 
neonates with RDS [2]. 
Bahbah et al., [36] found that there is no 
significant reduction in the activity of CAT, but SOD 
activity is significantly suppressed in the preterm 
group as compared to controls. 
Trindade et al., [37] obtained similar results as 
ours; they recorded a decrease in the activity of the 
antioxidant enzymes and an increased in the 
susceptibility to oxidative stress among premature 
neonates in comparison to controls immediately after 
birth. This could be explained by the development of 
antioxidant enzyme capacity in the third trimester, so 
the preterm group is at increased risk of oxidative 
stress [38].  
Pure oxygen use during resuscitation should 
be avoided. Restriction, the usage of mechanical 
ventilation by early usage of surfactant and nasal 
continuous positive air pressure, may decrease 
respiratory tissue damage in RDS patients [39]. 
In conclusion, the results obtained in this 
study indicate that the increased oxidative stress 
accompanied by reduced antioxidant defenses may 
play a significant role in the pathogenesis of 
respiratory distress in preterm new-borns.  
Further researches are recommended to 
study the protective role of antioxidant markers 
against RDS. Antioxidant modalities may be beneficial 
in the treatment of RDS cases and prevention of 
bronchopulmonary dysplasia. 
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